Breaking News Instant updates and real-time market news.

GILD

Gilead

$67.05

0.89 (1.35%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

08:36
05/15/18
05/15
08:36
05/15/18
08:36

Gilead's kite leases facility in the Netherlands to engineer cell therapies

Kite, a Gilead (GILD) company, announced it has leased a new facility in the Netherlands to engineer cell therapies in Europe. The 117,000 square-foot site in Hoofddorp will enable Kite to efficiently manufacture and deliver its cell therapies to people living with cancer in Europe and will provide more than 300 new jobs when fully operational in 2020. The facility will engineer and produce innovative cell therapies, including axicabtagene ciloleucel, a chimeric antigen receptor T cell, or CAR T, therapy that is currently under review by the European Medicines Agency and which is approved in the United States as Yescarta. In addition to the Netherlands facility, Kite has recently purchased a new building in Santa Monica from Astellas Pharma (ALPMY) that will be used for cell therapy research, development and the expansion of clinical manufacturing capabilities, and has leased a 26,000 square-foot facility in Gaithersburg, Maryland. The Maryland site will support the work of a new Cooperative Research and Development Agreement, or CRADA, with the National Cancer Institute to develop adoptive cell therapies targeting patient-specific tumor neoantigens. Neoantigens are mutations found on the surface of cancer cells that are unique to each person and tumor, offering the potential for more targeted antitumor activity.

GILD

Gilead

$67.05

0.89 (1.35%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

  • 15

    May

  • 18

    May

  • 21

    May

GILD Gilead
$67.05

0.89 (1.35%)

03/21/18
MSCO
03/21/18
NO CHANGE
Target $209
MSCO
Equal Weight
Bluebird Bio price target to $209 from $152 at Morgan Stanley
Morgan Stanley analyst Matthew Harrison raised his price target on Bluebird Bio (BLUE) to $209 from $152, stating that he now expects BCMA therapies to take 50% of the third line market by 2030 and noting that bb2121 has 50% market share there. The new assumptions increase his peak sales forecast to about $2.6B from about $1B, he pointed out. However, Harrison keeps an Equal Weight rating on Bluebird, stating that he would expect new data to be available at ASCO in June, but would also expect to see competitor data potentially from Celgene's (CELG) Juno, Gilead's (GILD) Kite, Johnson & Johnson's (JNJ) Nanjing Legend and others.
05/02/18
LEER
05/02/18
NO CHANGE
Target $72
LEER
Market Perform
Gilead price target lowered to $72 from $80 at Leerink
Leerink analyst Geoffrey Porges lowered his price target for Gilead to $72 from $80 after the company reported Q1 results and produced the first "significant disappointment" of the large cap biotech earnings season. The analyst reiterates a Market Perform rating on the shares.
05/02/18
JEFF
05/02/18
NO CHANGE
Target $95
JEFF
Buy
Gilead turnaround thesis unchanged after Q1 results, says Jefferies
Jefferies analyst Michael Yee says that while Gilead Sciences last night didn't report the best quarter, the turnaround thesis remains unchanged. The results won't prove the thesis to bears, but Gilead's turnaround is underway and should play out over the next four quarters, Yee tells investors in a post-earnings research note. The stock, trading at an 11-12 times price-to-earnings ratio, is "cheap" and the worst is mostly behind the company, Yee adds. He keeps a Buy rating on Gilead with a $95 price target.
05/02/18
MAXM
05/02/18
NO CHANGE
Target $89
MAXM
Buy
Gilead price target lowered to $89 from $94 at Maxim
Maxim analyst Jason McCarthy lowered his price target on Gilead to $89 after the company's Q1 results missed consensus, driven by lower than expected HIV/HBV revenues. The analyst has also reduced his FY18 EPS view to $6.14 from $6.74 and revenue to $20.5B from $21.4B, adding that while CAR-T treatment is promising, it is still a long way away. McCarthy keeps his Buy rating on Gilead, noting the company's "multiple" catalysts in 2018-2019 along with its $32B cash cushion that can expand the pipeline through M&A.
ALPMY Astellas Pharma
$0.00

(0.00%)

TODAY'S FREE FLY STORIES

GOOS

Canada Goose

$58.00

-0.04 (-0.07%)

18:50
09/25/18
09/25
18:50
09/25/18
18:50
Initiation
Canada Goose initiated  »

Canada Goose initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.91

-0.55 (-0.68%)

18:47
09/25/18
09/25
18:47
09/25/18
18:47
Periodicals
Philip Morris hits streets to sell older smokers on new devices, Bloomberg says »

Philip Morris is moving a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

URBN

Urban Outfitters

$40.06

-0.32 (-0.79%)

18:45
09/25/18
09/25
18:45
09/25/18
18:45
Initiation
Urban Outfitters initiated  »

Urban Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

SVMK

SurveyMonkey

$0.00

(0.00%)

18:35
09/25/18
09/25
18:35
09/25/18
18:35
Syndicate
SurveyMonkey 15M share IPO priced at $12.00 »

The shares are expected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

LULU

Lululemon

$158.42

1.04 (0.66%)

18:34
09/25/18
09/25
18:34
09/25/18
18:34
Initiation
Lululemon initiated  »

Lululemon initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROL

Rollins

$62.46

0.74 (1.20%)

, ANDV

Andeavor

$157.60

-1.41 (-0.89%)

18:30
09/25/18
09/25
18:30
09/25/18
18:30
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

ROL

Rollins

$62.46

0.74 (1.20%)

ANDV

Andeavor

$157.60

-1.41 (-0.89%)

INGN

Inogen

$258.49

5.5 (2.17%)

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

MPC

Marathon Petroleum

$85.04

-0.78 (-0.91%)

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

  • 19

    Oct

  • 27

    Nov

TJX

TJX

$110.33

0.605 (0.55%)

18:27
09/25/18
09/25
18:27
09/25/18
18:27
Initiation
TJX initiated  »

TJX initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.41

-0.08 (-2.29%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Hot Stocks
Breaking Hot Stocks news story on Community Health »

Community Health up 3.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$47.69

-0.01 (-0.02%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Conference/Events
Aflac to hold financial analysts briefing »

Financial Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TPC

Tutor Perini

$19.55

-0.275 (-1.39%)

18:12
09/25/18
09/25
18:12
09/25/18
18:12
Hot Stocks
Tutor Perini awarded $82M aircraft maintenance contract »

Tutor Perin announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLTH

Nobilis Health

$0.95

-0.0494 (-4.94%)

18:01
09/25/18
09/25
18:01
09/25/18
18:01
Hot Stocks
Nobilis Health names Kenny Klein new CFO »

Nobilis Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:57
09/25/18
09/25
17:57
09/25/18
17:57
Syndicate
FlexShopper 10M share Secondary priced at $1.00 »

Credit Suisse acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:55
09/25/18
09/25
17:55
09/25/18
17:55
Syndicate
FlexShopper 10M unit Secondary priced at $1.00 »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:48
09/25/18
09/25
17:48
09/25/18
17:48
Hot Stocks
Nike says Jordan brand 'incredibly strong' in China »

Says relationship with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:45
09/25/18
09/25
17:45
09/25/18
17:45
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says recent ad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CYH

Community Health

$3.41

-0.08 (-2.29%)

17:43
09/25/18
09/25
17:43
09/25/18
17:43
Hot Stocks
Community Health reaches settlement pact with DOJ over HMA probe »

Community Health Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike sees FY19 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Earnings
Nike sees 'strong' sequential revenue growth in Q2 »

Sees Q2 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

17:38
09/25/18
09/25
17:38
09/25/18
17:38
Hot Stocks
KB Home CEO sees slower sales in higher priced homes »

Comments from Q3 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MTBC

Medical Transcription Billing

$4.96

0.2 (4.20%)

17:36
09/25/18
09/25
17:36
09/25/18
17:36
Syndicate
Breaking Syndicate news story on Medical Transcription Billing »

Medical Transcription…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:34
09/25/18
09/25
17:34
09/25/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says has seen 17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GTX

Garrett Motion

$0.00

(0.00%)

, ACET

Aceto

$2.83

-0.09 (-3.08%)

17:30
09/25/18
09/25
17:30
09/25/18
17:30
Hot Stocks
Garrett Motion to replace Aceto in S&P 600 at open on October 2 »

Honeywell (HON) is…

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

NKE

Nike

$84.79

0.52 (0.62%)

17:27
09/25/18
09/25
17:27
09/25/18
17:27
Hot Stocks
Nike says has returned to 'strong, sustainable growth' in North America »

Says facets of live story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RBNC

Reliant Bancorp

$25.91

-0.27 (-1.03%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Reliant Bancorp raises quarterly cash dividend 33% from last year »

Reliant Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

, INGN

Inogen

$258.49

5.5 (2.17%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Vanda Pharmaceuticals, Inogen »

Vanda Pharmaceuticals to…

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

INGN

Inogen

$258.49

5.5 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 09

    Oct

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.